Monica Milano

718 total citations
22 papers, 489 citations indexed

About

Monica Milano is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Monica Milano has authored 22 papers receiving a total of 489 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 11 papers in Pulmonary and Respiratory Medicine and 10 papers in Cancer Research. Recurrent topics in Monica Milano's work include Advanced Breast Cancer Therapies (9 papers), Cancer Treatment and Pharmacology (8 papers) and Breast Cancer Treatment Studies (7 papers). Monica Milano is often cited by papers focused on Advanced Breast Cancer Therapies (9 papers), Cancer Treatment and Pharmacology (8 papers) and Breast Cancer Treatment Studies (7 papers). Monica Milano collaborates with scholars based in Italy, United States and Germany. Monica Milano's co-authors include Grazia Arpino, Sabino De Placido, Giuseppe Curigliano, Carmen Criscitiello, Marzia Locatelli, Angela Espósito, Filippo de Braud, Claudia Maggi, Claudio Vernieri and Gabriella Mariani and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and Annals of Oncology.

In The Last Decade

Monica Milano

18 papers receiving 480 citations

Peers

Countries citing papers authored by Monica Milano

Since Specialization

Citations

This map shows the geographic impact of Monica Milano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Monica Milano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Monica Milano more than expected).

Fields of papers citing papers by Monica Milano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Monica Milano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Monica Milano. The network helps show where Monica Milano may publish in the future.

Co-authorship network of co-authors of Monica Milano

This figure shows the co-authorship network connecting the top 25 collaborators of Monica Milano. A scholar is included among the top collaborators of Monica Milano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Monica Milano. Monica Milano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	336P Approaches for locoregional optimization in oligometastatic and oligopersistent metastatic breast cancer 2025 ·ESMO Open ·(unknown), (unknown), Monica Milano, Nadia Bianco, Carmine Valenza, (unknown), Maria Cavallone, (unknown), (unknown), Paolo Della Vigna, Guido Bonomo, Gianluca Maria Varano, Daniele Maiettini, (unknown), (unknown), Elisabetta Munzone, (unknown), Franco Orsi	0
2	Real-world safety and efficacy profiles of trastuzumab deruxtecan in patients with advanced breast cancer 2025 ·ESMO Open ·Gabriele Antonarelli, Monica Milano, (unknown), (unknown), (unknown), Dario Trapani, Silvia Dellapasqua, Alessandro Marra, (unknown), Carmine Valenza, (unknown), Elisabetta Munzone, (unknown)	0
3	Extended endocrine therapy after 5 years of adjuvant LHRH-agonist in premenopausal patients with node-positive hormone receptor (HR)-positive early breast cancer. 2025 ·Journal of Clinical Oncology ·Carmine Valenza, (unknown), Monica Milano, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Gabriele Antonarelli, Fabio Conforti, Eleonora Pagan, Vincenzo Bagnardi, Gregory J. Kirkner, Dario Trapani, (unknown), Elisabetta Munzone, Giuseppe Curigliano, Ann H. Partridge	1
4	Validation of the ONKOTEV Risk Prediction Model for Venous Thromboembolism in Outpatients With Cancer 2023 ·JAMA Network Open ·Chiara Alessandra Cella, (unknown), Marcia Hall, Michele Arcopinto, Vincenzo Bagnardi, Lorenzo Gervaso, (unknown), Francesca Spada, Maria Giulia Zampino, Paola Simona Ravenda, Samuele Frassoni, Antonio Passaro, Monica Milano, (unknown), Nicola Fazio, Florian Lordick	13
5	Outcome of patients with metastatic triple negative breast cancer treated with first-line chemotherapy: a single institution retrospective analysis 2021 ·Breast Cancer Research and Treatment ·Nadia Bianco, Monica Milano, Eleonora Pagan, Chiara Oriecuia, Vincenzo Bagnardi, Elena Guerini‐Rocco, (unknown), G. Peruzzotti, Marco Colleoni, Giuseppe Viale	1
6	Adjuvant treatment for triple negative breast cancer with residual tumor after neo-adjuvant chemotherapy. A single institutional retrospective analysis 2021 ·The Breast ·Nadia Bianco, Antonella Palazzo, Eleonora Pagan, Vincenzo Bagnardi, Monica Milano, (unknown), Marco Colleoni	2
7	Resistance mechanisms to anti-HER2 therapies in HER2-positive breast cancer: Current knowledge, new research directions and therapeutic perspectives 2019 ·Critical Reviews in Oncology/Hematology ·Claudio Vernieri, Monica Milano, Marta Brambilla, Alessia Mennitto, Claudia Maggi, Maria Silvia Cona, Michele Prisciandaro, Chiara Fabbroni, Luigi Celio, Gabriella Mariani, Giulia Bianchi, Giuseppe Capri, Filippo de Braud	158
8	Evaluation of endocrine therapy and patients preferences in early breast cancer: Results of Elena study 2019 ·Annals of Oncology ·Emilia Montagna, Eleonora Pagan, Vincenzo Bagnardi, Marco Colleoni, Giuseppe Cancello, Elisabetta Munzone, Silvia Dellapasqua, Nadia Bianco, (unknown), Monica Iorfida, Massimiliano Mazza, (unknown), Monica Milano, Paolo Veronesi, Claudia Sangalli, (unknown), Gabriella Pravettoni, Ketti Mazzocco, Viviana Galimberti	0
9	The neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict efficacy of platinum-based chemotherapy in patients with metastatic triple negative breast cancer 2018 ·Scientific Reports ·Claudio Vernieri, Alessia Mennitto, Michele Prisciandaro, Veronica Huber, Monica Milano, L. Rinaldi, Maria Silvia Cona, Claudia Maggi, (unknown), Siranoush Manoukian, Gabriella Mariani, Giulia Bianchi, Giuseppe Capri, Licia Rivoltini, Filippo de Braud	45
10	Single-Agent Gemcitabine vs. Carboplatin-Gemcitabine in Advanced Breast Cancer: A Retrospective Comparison of Efficacy and Safety Profiles 2018 ·Clinical Breast Cancer ·Claudio Vernieri, Michele Prisciandaro, Monica Milano, Maria Silvia Cona, Claudia Maggi, Marta Brambilla, Alessia Mennitto, Chiara Fabbroni, Elena Farè, Sara Cresta, Luigi Celio, Gabriella Mariani, Giulia Bianchi, Giuseppe Capri, Filippo de Braud	11
11	Abstract B022: Metabolic and immunologic effects of the fasting mimicking diet in cancer patients 2018 ·Molecular Cancer Therapeutics ·Filippo de Braud, Claudio Vernieri, Veronica Huber, Agata Cova, Paola Squarcina, Monica Milano, Giovanni Fucà, Valter D. Longo, Licia Rivoltini	2
12	Antitumor activity and safety profile of weekly carboplatin plus paclitaxel in metastatic breast cancer: a ten-year, monocentric, retrospective study 2017 ·Breast Cancer Research and Treatment ·Claudio Vernieri, Monica Milano, Alessia Mennitto, Claudia Maggi, (unknown), L. Rinaldi, (unknown), (unknown), (unknown), Gabriella Mariani, Giulia Bianchi, Giuseppe Capri, Filippo de Braud	9
13	Chemotherapy versus endocrine therapy as first-line treatment in patients with luminal-like HER2-negative metastatic breast cancer: A propensity score analysis 2016 ·The Breast ·Marta Bonotto, Lorenzo Gerratana, Massimo Di Maïo, Carmine De Angelis, M. Cinausero, (unknown), Monica Milano, Brigida Stanzione, Piera Gargiulo, Donatella Iacono, Alessandro Marco Minisini, Mauro Mansutti, Gianpiero Fasola, Sabino De Placido, Grazia Arpino, Fabio Puglisi	38
14	Long-term survival and BRCA status in male breast cancer: a retrospective single-center analysis 2016 ·BMC Cancer ·Piera Gargiulo, Matilde Pensabene, Monica Milano, Grazia Arpino, Mario Giuliano, Valeria Forestieri, (unknown), Rossella Lauria, Sabino De Placido	32
15	First line treatment in patients with luminal-like metastatic breast cancer: a propensity score-matched analysis 2015 ·Annals of Oncology ·Marta Bonotto, Lorenzo Gerratana, Grazia Arpino, Massimo Di Maïo, Carmine De Angelis, Donatella Iacono, M. Cinausero, Monica Milano, Piera Gargiulo, Caterina Fontanella, (unknown), (unknown), Alessandro Marco Minisini, Mauro Mansutti, Gianpiero Fasola, Sabino De Placido, Fabio Puglisi	1
16	Liquid biopsies for solid tumors: Understanding tumor heterogeneity and real time monitoring of early resistance to targeted therapies 2015 ·Pharmacology & Therapeutics ·Angela Espósito, Carmen Criscitiello, Marzia Locatelli, Monica Milano, Giuseppe Curigliano	84
17	Features of aggressive breast cancer 2015 ·The Breast ·Grazia Arpino, Monica Milano, Sabino De Placido	55
18	Combination of Cytotoxic Drugs for Patients with HER2-Negative Metastatic Breast Cancer 2013 ·INFM-OAR (INFN Catania) ·Carmine De Angelis, Monica Milano, Brigida Stanzione, Piera Gargiulo, Sabino De Placido, Grazia Arpino	2
19	Long-term disease control with lapatinib and capecitabine in a patient with HER2-positive metastatic breast cancer pretreated with trastuzumab and trastuzumab-emtansine 2013 ·Tumori Journal ·Carmine De Angelis, Monica Milano, Piera Gargiulo, Brigida Stanzione, Valeria Forestieri, Rossella Lauria, Matilde Pensabene, Felice D’Arco, Sabino De Placido, Grazia Arpino	0
20	Evaluation of the sensitivity of two highly sensitive troponin assays for early detection of non ST- elevation myocardial infarction (NSTEMI) 2011 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·(unknown), Alberto Dolci, Annalisa Cavallero, (unknown), Ilenia Infusino, Monica Milano, Mara Rubino, Giancarlo Marenzi, Mauro Panteghini	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact